Related Experiment Video
Updated: Jun 17, 2026

One-day Workflow Scheme for Bacterial Pathogen Detection and Antimicrobial Resistance Testing from Blood Cultures
Published on: July 9, 2012
Introducing a New Polymerase Chain Reaction Panel-Based Cerebrospinal Fluid Evaluation for Encephalitis and
Fabian Sidler1, Pascal Bittel2, Jonas Marschall3,4
1Department of Visceral Surgery and Medicine, Inselspital Bern University Hospital, University of Bern, Bern, Switzerland.
Abstract:
We analyzed the impact of a diagnostic meningitis/encephalitis polymerase chain reaction panel. Introducing the test resulted in no significantly shortened empiric antibiotic streptococcal/meningococcal treatment (-1 day [95% confidence interval {CI}, 0-3 days]; P = .16), nor hospitalization (-2 days [95% CI, 0-3 days]; P = .86). Empiric treatment duration against Herpesviridae and Listeria monocytogenes remained unchanged, and pathogen-specific diagnoses were not increased.
Insights
The new meningitis/encephalitis polymerase chain reaction panel did not shorten antibiotic treatment or hospital stays. This diagnostic tool did not increase pathogen-specific diagnoses for common causes like Streptococcus or Listeria.
Area of Science:
- Infectious Disease
- Clinical Diagnostics
- Microbiology
Background:
- Meningitis and encephalitis are serious infections requiring prompt diagnosis and treatment.
- Empiric antibiotic therapy is often initiated before a definitive pathogen is identified.
- Novel diagnostic panels aim to improve the speed and accuracy of pathogen detection.
Purpose of the Study:
- To evaluate the clinical impact of a diagnostic meningitis/encephalitis polymerase chain reaction (PCR) panel.
- To assess whether the PCR panel shortened empiric antibiotic treatment duration.
- To determine if the panel affected hospitalization length or increased pathogen-specific diagnoses.
Main Methods:
- Retrospective analysis of patient data before and after the introduction of the meningitis/encephalitis PCR panel.
- Comparison of empiric antibiotic treatment duration for Streptococcus and Neisseria meningitidis.
- Evaluation of hospitalization duration and rates of pathogen-specific diagnoses.
Main Results:
- Introduction of the PCR panel did not significantly shorten empiric antibiotic treatment duration for streptococcal/meningococcal infections (-1 day; P = .16).
- Hospitalization duration also showed no significant change (-2 days; P = .86).
- Empiric treatment durations for Herpesviridae and Listeria monocytogenes remained unchanged, and pathogen-specific diagnoses did not increase.
Conclusions:
- The diagnostic meningitis/encephalitis PCR panel did not demonstrate a significant impact on reducing empiric antibiotic use or hospitalization length in this analysis.
- The panel did not lead to an increase in specific pathogen identification compared to previous diagnostic approaches.
- Further studies may be needed to explore the utility and optimal implementation of such panels in clinical practice.
Related Concept Videos
Bacterial Meningitis
Viral Meningitis
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology

